Abstract
Hepatocellular carcinoma (HCC is extremely common in sub-Saharan Africa and the Far East. In high incidence areas it presents in young to middle-aged adults with an 8:1 male predominance, a relatively acute onset of symptoms, and a rapid clinical course. In contrast in the United States and Europe it is relatively uncommon and occurs predominantly in elderly individuals (2.5:1 male predominance). HCC frequently develops on the basis of alcohol-or hepatitis-related cirrhosis, which presents with an insidious onset of symptoms and a more protracted clinical course. In the following, imaging features concerning the morphology of HCC in unenhanced and contrast-enhanced MRI are presented. Special emphasis is placed on the differential diagnostic criteria versus other hepatic tumors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bartolozzi C, Lencioni R, Caramella D, Paolicchi A, Russo R, Romani R (1994) The magnetic resonance and histological correlations in hepatocellular carcinoma. Radiol Med 87:90–95
Bellin M, Zaim S, Auberton E, et al (1994) Liver metastases: safety and efficacy of detection with superparamagnetic iron oxide in MR imaging. Radiology 193:657–663
Bernardino ME, Young SW, Lee JKT, et al (1992) Hepatic MR imaging with Mn-DPDP: safety, image quality, and sensitivity. Radiology 183:53–58
Blakeborough A, Ward I, Wilson D, et al (1997) Hepatic lesion detection at MR imaging: a comparative study with four sequences. Radiology 203:759–765
Brasch RC (1992) New directions in the development of MR imaging contrast media. Radiology 183:1–11
Caseiro Alves F, Zins M, Mahfouz AE, et al (1996) Calcification in focal nodular hyperplasia: a new problem for differentiation from fibrolamellar hepatocellular carcinoma. Radiology 198:889–892
Caudana R, Morasna G, Pirovano GP (1996) Focal malignant hepatic lesions: MR imaging enahnced with gadolinium benzyloxy-propionictetra-acetate (BOPTA) - preliminary results of phase II clinical application. Radiology 199:513–520
Choi BI, Lee GK, Kim ST, Han MC (1990) Mosaic pattern of encapsulated hepatocellular carcinoma: correlation of magnetic resonance imaging and pathology. Gastrointest Radiol 15:238–240
Corrigan K, Semelka RC (1995) Dynamic contrast-enhanced MR imaging of fibrolamellar hepatocellular carcinoma. Abdom Imaging 20:122–125
De Santis M, Romagnoli R, Cristani A, et al (1992) MRI of small hepatocellular carcinoma: comparison with US, CT, DSA, and Lipiodol-CT. 1 Comput Assist Tomogr 16:189–197
Denys A, Arrive L, Servois V, et al (1994) Hepatic tumors: detection and characterization at 1-T MR imaging enhanced with AMI-25. Radiology 193:665–669
Ebara M, Watanabe S, Kita K, et al (1991) MR imaging of small hepatocellular carcinoma: effect of intratumoral copper content on signal intensity. Radiology 180:617–621
Elizondo G, Fretz C, Stark DD, et al (1991) Preclinical evaluation of Mn-DPDP: new paramagnetic hepatobiliary contrast agent for MR imaging. Radiology 178:73–78
Fretz CJ, Stark DD, Metz CE, et al (1990) Detection of hepatic metastases: comparison of contrast-enhanced CT, unenhanced MR imaging, and iron oxide-enhanced MR imaging. AIR 155: 763–770
Hahn PF, Stark DD, Weissleder R, Elizondo G, Saini S, Ferrucci IT (1990) Clinical application of super-paramagnetic iron oxide to MR imaging of tissue perfusion in vascular liver tumors. Radiology 174:361–366
Hamm B, Staks T, Taupitz M, et al (1994) Contrast-enhanced MR imaging of liver and spleen: first experience in humans with a new superparamagnetic iron oxide. JMRI 4:659–668
Hamm B, Staks T, Muhler A (1995) Phase I clinical evaluation of Gd-EOB;-DTPA as a hepatobiliary contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 195:785–792
Hammerstingl R, Vogl ThJ, Schwarz W (1997) Detection and differential diagnosis of focal liver lesions: comparison of iron oxide-enhanced and gadolinium-enhanced MRI in the same patient. Results of a ROC analysis. Radiology 205(P):318–322
Hammerstingl R, Vogl ThJ, Schwarz W (1998) Contrast-enhanced MRI of focal liver lesions: differentiation and detection of primary and secondary liver lesions using Resovist-enhanced versus gadolinium-enhanced MRI in the same patient. Acta Radiol 5:75–79
Harisinghani M, Saini S, Weissleder R, et al (1997) Differentiation of liver hemangiomas from metastases and hepatocellular carcinomas at MR imaging enhanced with blood-pool contrast agent code-7227. Radiology 202:687–691
Hirai K, Aoki Y, Majima Y, et al (1991) Magnetic resonance imaging of small hepatocellular carcinoma. Am I Gastroenterol 86:205–210
Honda H, Kaneko K, Kanazawa Y, et al (1997) MR imaging of hepatocellular carcinomas: effect of Cu and Fe contents on signal intensity. Abdom Imaging 22:60–66
Ichikawa T, Haradome H, Hachiya J, Nitatori T, Araki T (1998) Diffusion-weighted MR imaging with a single-shot echoplanar sequence: detection and characterization of focal hepatic lesions. AIR 170:397–40
Imaeda T, Kanematsu M, Mochizuki R, Goto H, Saji S, Shimokawa K (1994) Extracapsular invasion of small hepatocellular carcinoma: MR and CT findings. J Comput Assist Tomogr 18:755–760
Inoue E, Kuroda C, Fujita M, et a1 (1993) MR features of various histological grades of small hepatocellular carcinoma. J Comput Assist Tomogr 17:75–79
Itai Y, Ohtomo K, Furui S, Minami M, Yoshikawa K, Yashiro N (1986) MR imaging of hepatocellular carcinoma. J Comput Assist Tomogr 10:963–968
Itoh K, Nishimura K, Togashi K, et al (1987) Hepatocellular carcinoma: MR imaging. Radiology 164:21–25
Kanematsu M, Hoshi H, Murakami T, eta! (1997) Detection of hepatocellular carcinoma in patients with cirrhosis: MR imaging versus angiographically assisted helical CT. AJR 169:1507–1515
kawamori Y, Matsui O, kadoya M, Yoshikawa J, Demachi H, Takashima T (1992) Differentiation of hepatocellular carcinomas from hyperplastic nodules induced in rat liver with ferrite-enhanced MR imaging. Radiology 183:65–72
Kelekis NL, Semelka RC, Worawattanakul S, et al (1998) Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images. AJR 170:1005–1009
Kim T, Murakami T, Oi H, et al (1995) Detection of hypervascular hepatocellular carcinoma by dynamic MRI and dynamic spiral CT. J Comput Assist Tomogr 19:948–954
Kitagawa K, Matsui O, kadoya M, et al (1991) Hepatocellular carcinomas with excessive copper accumulation: CT and MR findings. Radiology 180:623–628
Kopp AF, Laniado M, Dammann F, et al (1997) MR imaging of the liver with Resovist: safety, efficacy, and pharmocaodynamic properties. Radiology 204:749–756
Lencioni R, Mascalchi M, Caramella D, Bartolozzi C (1996) Small hepatocellular carcinoma: differentiation from adenomatous hyperplasia with color Doppler US and dynamic Gd-DTPA-enhanced MR imaging. Abdom Imaging 21:41–48
Liou J, Lee JK, Borrello JA, Brown JJ (1994) Differentiation of hepatomas from nonhepatomatous masses: use of MnDPDP-enhanced MR images. Magn Reson Imaging 12:71–79
Mahfouz AE, Hamm B, Taupitz M (1993a) Hypervascular liver lesions: differentiation of focal nodular hyperplasia from malignant tumors with dynamic gadolinium-enhanced MR imaging. Radiology 186:133–138
Mahfouz AE, Hamm B, Wolf KJ (1993b) Dynamic gadopenteteate dimeglumine-enhanced MR imaging of hepatocellular carcinoma. Eur Radiol 3:453–458
Mahfouz AE, Hamm B, Wolf KJ (1994) Peripheral washout: a sign of malignancy on dynamic gadolinium-enhanced MR images of focal liver lesions. Radiology 190:49–52
Marchal G, Van HP, Demaerel P, et al (1989) Detection of liver metastases with superparamagnetic iron oxide in 15 patients: results of MR imaging at 1.5 T. AJR 152:771–775.
Marchal G, Zhang X, Ni Y, Hecke PVan, Yu J, Baert AL (1993) Comparison between Gd-DTPA, Gd-EOB-DTPA, and MnDPDP in induced HCC in rats: a correlation study of MR imaging, microangiography, and histology. Magn Reson Imaging 11:665–674
Martin J, Sentis M, Zidan A, et al (1995) Fatty metamorphosis of hepatocellular carcinoma: detection with cl emical shift gradient-echo MR imaging. Radiology 195:125–130
Matsuzaki K, Sano N, Hashiguchi N, Yoshida S, Nishitani H (1997) Influence of copper on MRI of hepatocellular carcinoma. JMRI 7(3):478–481
Mergo P, Helmberger T, Nicolas A, et al (1996) Ring enhanement in ultrasmall superparamagnetic iror oxide MR imaging: a potential new sign for characteriza:ion of liver lesions. AJR 166:379–384
Mitchell DG, Palazzo J, Hann HW, Rifkin MD, Burk DL, Rubin R (1991) Hepatocellular tumors with high signal In T1-weighted MR images: chemical shift MR imaging and histologic correlation. I Comput Assist Tomogr 15:762–769
Murakami T, Baron RL, Peterson MS (1996) Hepatocellular carcinoma: MR imaging with Mangafodipir Trisodium (Mn-DPDP). Radiology 200:69–77
Muramatsu Y, Nawano S, Takayasu K, et al (1991) Early hepatocellular carcinoma: MR imaging. Radiology 18::209–213
Muramatsu M, Takayasu K, Furukawa Y, et al (1997) H patic tumor invasion of bile ducts: Wedge-shaped sign on MR images. Radiology 205:81–85
Ni Y, Marchal G, Yu J, et al (1993) Experimental liver ca] leers: Mn-DPDP-enhanced rims in MR-microangiographi --histologic correlation study. Radiology 188:45–51
Ohtomo K, Matsuoka Y, Abe O, et al (1997) High-resolution MR imaging evaluation of hepatocellular carciroma. Abdom Imaging 22:182–186
Oudkerk M, Heuvel AG, Wielopolski P, et al (1997) Hepatic lesions: detection with ferumoxide-enhanced T1-weighted MR imaging. Radiology 203:449–456
Peterson MS, Baron RL, Murakami T (1996) Hepatic malignancies: usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging. Radiology 201:337–345
Reimer P, Rummeny EJ, Daldrup HE, et a1 (1995) Clinical results with Resovist: a phase 2 clinical trial. Radiology 195:489–496
Reimer P, Rummeny EJ, Shamsi K, et al (1996) Clinical results with Gd-EOB-DTPA: dose finding, safety aspects, and pulse sequences evaluation within a hase II trial. Ra.:liology 199:177–183
Reimer P, Rummeny EJ, Daldrup HE, et al (1997) Enhancement characteristic of liver metastases, hepatocel ular carcinomas, and hemangiomas with Gd-EOB-DTPA: preliminary results with dynamic MR imaging. Eur Radio! 7:275–280
Rocklage SM, Worah D, Kim SH (1991) Metal ion release from paramagnetic chelates: what is tolerable? Magn Reson Med 11:509–519
Rofsky NM, Weinreb JC, Bernardino ME, et al (1993) Hepatocellular Tumors: characterization with Mn-DPDP-enhanced MR imaging. Radiology 188:53–59
Rummeny E, Saini S, Wittenberg J, et al. (1989a) MR imaging of liver neoplasms. AJR 152:493–499
Rummeny E, Weissleder R, Sironi S, Stark DD, et a1 (1989b) Central scars in primary liver tumors: MR features, specificity, and pathologic correlation. Radiology 171:323–326
Rummeny E, Weissleder R, Stark DD, Saini S, et a1 (1989CJ Primary liver tumors: diagnosis by MR imaging. AJR 152:63–72
Sadek AG, Mitchell DG, Siegeluran ES, Outwater BK, Matteucci T, Hann HW (1995) Early hepatocellular carcinoma that develops within macroregenerative nodules: growth rate depicted at serial MR imaging. Radiology 195:753–756
Scharf J, Hoffmann V, Lehnert T, et al (1998) Pseudolesions at T1-weighted gradient-echo imaging after administration of superparamagnetic iron oxide: comparison with portal perfusion abnormalities at CT during arterial portography. Radiology 207:67–72
Seneterre E, Taourel, Bouvier Y, et al (1996) Detection of hepatic metastases: ferrumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. Radiology 200:785–792
Shamsi K, Balzer T, Saini S, et al (1998): Superparamagnetic iron oxide particles (SHU 555 A): evaluation of efficacy in three doses for hepatic MR imaging. Radiology 206:365–371
Stark DD, Weissleder R, Elizondo G, et al (1988) Superparamagnetic iron oxide: clinical applicaation as a contrast agent for MR imaging of the liver. Radiology 168:297–301
Titelbaum DS, Burke DR, Meranze SG, Saul SH (1988) Fibrolamellar hepatocellular carcinoma: pitfalls in nonoperative diagnosis. Radiology 167:25–30
Tweedle MF (1997) The ProHance story: the making of a novel MRI contrast agent. Eur Radiol 7:225–230
Ueda K, Kitagawa K, Kadoya M, Matsui O, Takashima T, Yamahana T (1995) Detection of hypervascular hepatocellular carcinoma by using spiral volumetric CT: comparison of US and MR imaging. Abdom Imaging 20:547–553
van Beers BE, Grandin C, Pauwels S, et al (1994) Gd-EOBDTPA enhancement pattern of hepatocellular carcinomas in rats: comparison with Tc-99m-IDA uptake. JMRI 4:351354
Vogl ThJ, Pegios W, McMahon C, et al (1992) Gadobenate dimeglumine - a new contrast agent for MR imaging: preliminary evaluation in healthy volunteers. AJR 158:887
Vogl ThJ, Hamm B, Schnell B, et al (1993) Mn-DPDP enhancement patterns of hepatocellular lesions on MR images. JMRI 3:51–56
Vogl ThJ, Hammerstingl R, Schwarz W (1996a) Magnetic resonance iamging of focal liver lesions. Comparison of the superparamagnetic iron oxide Resovist versus Gadolinium-DTPA in the same patient. Investigative Radiology 31:696–708
Vogl ThJ, Kümmel S, Hammerstingl R, et al (1996b) Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology 200:59–63
Vogl TJ, Hammerstingl R, Schwarz W (1996CJ Superparamagnetic iron oxide-enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions. Radiology 198:881–887
Vogl ThJ, Hammerstingl R, Schwarz W (1997a) Iron oxide-enhanced MR imaging of focal liver lesions: clinical single center outcome study in 700 patients. Radiology 205(P):457–452
Vogl ThJ, Schwarz W, Hammerstingl R (1997b) Dynamic and static SPIO-enhanced MR imaging in focal liver lesions. Radiology 205(P):456–461
Vogl ThJ, Stupaysky A, Pegios W, Hammerstingl R (1997CJ Hepatocellular carcinoma: Evaluation with dynamic and static gadobenate dimeglumine-enhanced MR imaging and histopathologic correlation. Radiology 205:721–728
Weinmann MJ, Brasch RC, Press WR, et al (1984) Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. AJR 142:619–624
Weissleder R (1994) Liver MR imaging with iron oxides: toward consensus and clinical practice. Radiology 193:593–595
Winter TCr, Takayasu K, Muramatsu Y, et al (1994) Early advanced hepatocellular carcinoma: evaluation of CT and MR appearance with pathologic correlation. Radiology 192:379–387
Yamamoto H, Yamashita Y, Yoshimatsu S, et al (1995) Hepatocellular carcinoma in cirrhotic livers: detection with unenhanced and iron oxide-enhanced MR imaging. Radiology 195:106–112
Yamashita Y, Fan ZM, Yamamoto H, et al (1993) Sclerosing hepatocellular carcinoma: radiologic findings. Abdom Imaging 18:347–351
Yamashita Y, Fan ZM, Yamamoto H, et al (1994) Spin-echo and dynamic gadolinium-enhanced FLASH MR imaging of hepatocellular carcinoma: correlation with histopathologic findings. JMRI 4:83–90
Yamashita Y, Mitsuzaki K,Yi T, et al (1996) Small hepatocellular carcinoma in patients with chronic liver damage: prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver. Radiology 200:79–84
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Vogl, T.J., Hammerstingl, R. (1999). Magnetic Resonance Imaging of Hepatocellular Carcinoma. In: Bartolozzi, C., Lencioni, R. (eds) Liver Malignancies. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-58641-5_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-58641-5_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63679-0
Online ISBN: 978-3-642-58641-5
eBook Packages: Springer Book Archive